{"id":{"repo_id":"denver","oai_identifier":"oai:digitalcommons.du.edu:etd-3118"},"canonical_url":"https://search.ndltd.org/etd/denver/oai:digitalcommons.du.edu:etd-3118","repository":{"repo_id":"denver","name":"University of Denver","base_url":"https://digitalcommons.du.edu/do/oai/"},"display":{"title":"Inhibition of de novo and the Prion-Like Spread of Amyloidogenesis Using in vitro and in vivo Disease Models","abstract":"The aberrant fibrous, extracellular, and intracellular proteinaceous deposits in cells, organs and tissues are referred to as amyloids. These deposits are dominated by β-sheet structures that have been implicated in several neurodegenerative diseases and cancer. In this work, the types of amyloidosis studied include Parkinson’s disease (PD) using UA196 and NL5901 strains of Caenorhabditis elegans (C. elegans), Alzheimer’s disease (AD) using GMC101 strain of C. elegans, and cancer-associated mutant p53 aggregation in MIA PaCa-2 mutant cells. Several molecules including SK-129, NS132, NS163, bexarotene, a polyphenol (-)-epi-gallocatechine gallate (EGCG), ADH40, RD148, and RD242 were screened in vitro and in vivo while studying the inhibition of the amyloid protein aggregation. Also, the prion-like spread of amyloid fibrils was studied (through secondary nucleation) in NL5901 strain of C. elegans using α-Synuclein (αS) preformed fibrils and in MIA-PaCa-2 cells using p53 preformed fibrils. Various techniques were used in this study including paralysis assay, Thioflavin T (ThT) assay, immunofluorescence (IF) assay, confocal imaging, Proteomics analysis, Western Blot (WB) analysis to study the locomotion of C. elegans, to determine the amyloid fibril content in vitro and in vivo, determine upregulated and downregulated proteins in cells, and identify target proteins through immunoblotting of cell lysates, respectively. Oligopyridylamides (OPs) and Oligoquinolines (OQs) displayed remarkable neuroprotective effects in DA neurons and rescued various PD phenotypes of C. elegans, including rescue of degeneration of DA neurons, improved motility rate, decreased reactive oxygen species, food-sensing behavioral deficits, and rescue of dopamine synthesis. Also, we demonstrated that OPs rescue PD phenotypes when administered to the post-disease-onset C. elegans model. The results from this study proposed that SK-129, NS132, NS163, bexarotene, EGCG, ADH40, RD148, and RD242 are potent antagonists for amyloid protein aggregation.","abstract_html":"The aberrant fibrous, extracellular, and intracellular proteinaceous deposits in cells, organs and tissues are referred to as amyloids. These deposits are dominated by β-sheet structures that have been implicated in several neurodegenerative diseases and cancer. In this work, the types of amyloidosis studied include Parkinson’s disease (PD) using UA196 and NL5901 strains of Caenorhabditis elegans (C. elegans), Alzheimer’s disease (AD) using GMC101 strain of C. elegans, and cancer-associated mutant p53 aggregation in MIA PaCa-2 mutant cells. Several molecules including SK-129, NS132, NS163, bexarotene, a polyphenol (-)-epi-gallocatechine gallate (EGCG), ADH40, RD148, and RD242 were screened in vitro and in vivo while studying the inhibition of the amyloid protein aggregation. Also, the prion-like spread of amyloid fibrils was studied (through secondary nucleation) in NL5901 strain of C. elegans using α-Synuclein (αS) preformed fibrils and in MIA-PaCa-2 cells using p53 preformed fibrils. Various techniques were used in this study including paralysis assay, Thioflavin T (ThT) assay, immunofluorescence (IF) assay, confocal imaging, Proteomics analysis, Western Blot (WB) analysis to study the locomotion of C. elegans, to determine the amyloid fibril content in vitro and in vivo, determine upregulated and downregulated proteins in cells, and identify target proteins through immunoblotting of cell lysates, respectively. Oligopyridylamides (OPs) and Oligoquinolines (OQs) displayed remarkable neuroprotective effects in DA neurons and rescued various PD phenotypes of C. elegans, including rescue of degeneration of DA neurons, improved motility rate, decreased reactive oxygen species, food-sensing behavioral deficits, and rescue of dopamine synthesis. Also, we demonstrated that OPs rescue PD phenotypes when administered to the post-disease-onset C. elegans model. The results from this study proposed that SK-129, NS132, NS163, bexarotene, EGCG, ADH40, RD148, and RD242 are potent antagonists for amyloid protein aggregation.","abstract_has_math":false,"creators":["Joseph, Johnson Anazoba"],"institution":null,"degree_name":"M.S.","degree_level":"Masters Thesis","degree_discipline":null,"degree_department":null,"school":null,"contributors":["Sunil Kumar","Daniel Linseman","Martin Margittai","Michelle K. Knowles"],"advisors":[],"committee_chairs":[],"committee_members":[],"year":null,"date_issued":"","date_published":null,"updated_at":"2026-11-19T07:54:25Z","subjects":["Alzheimer's disease","Amyloids","Caenorhabditis elegans","Cancer","Neurodegenerative diseases","Parkinson's disease","Biochemistry","Biochemistry, Biophysics, and Structural Biology","Cancer Biology","Cell and Developmental Biology","Cell Biology"],"languages":["en"],"rights":["<p>Copyright is held by the author. User is responsible for all copyright compliance.</p>","Johnson Anazoba Joseph"],"rights_urls":[],"identifier_entries":[],"person_identifier_entries":[]},"links":{"outbound_url":"https://digitalcommons.du.edu/etd/2120","outbound_label":"Repository record","outbound_source":"dc:identifier","record_url":"https://digitalcommons.du.edu/etd/2120","record_label":"Repository record","record_kind":"record","record_source":"dc:identifier","download_url":null,"download_label":null,"download_source":null,"access_status":null,"embargo_until":null,"access_note":null},"source_record":{"url":"https://digitalcommons.du.edu/do/oai/?verb=GetRecord&metadataPrefix=oai_etdms&identifier=oai%3Adigitalcommons.du.edu%3Aetd-3118","prefix":"oai_etdms"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor","label":"Contributor","values":["Sunil Kumar","Daniel Linseman","Martin Margittai","Michelle K. Knowles"]},{"key":"dc:creator","label":"Author","values":["Joseph, Johnson Anazoba"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date.available","label":"Dc Date Available","values":["2023-04-30T07:00:00Z"]},{"key":"dc:date.copyright","label":"Dc Date Copyright","values":["2022-01-01T08:00:00Z"]},{"key":"dc:date.created","label":"Dc Date Created","values":["2022-01-01T08:00:00Z"]},{"key":"thesis:degree_level","label":"Degree Level","values":["Masters Thesis"]},{"key":"thesis:degree_name","label":"Degree Name","values":["M.S."]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["Alzheimer's disease","Amyloids","Caenorhabditis elegans","Cancer","Neurodegenerative diseases","Parkinson's disease","Biochemistry","Biochemistry, Biophysics, and Structural Biology","Cancer Biology","Cell and Developmental Biology","Cell Biology"]}]},{"id":"language_rights","label":"Language and Rights","entries":[{"key":"dc:language","label":"Dc Language","values":["en"]},{"key":"dc:rights","label":"Dc Rights","values":["<p>Copyright is held by the author. User is responsible for all copyright compliance.</p>"]},{"key":"dc:rights.holder","label":"Dc Rights Holder","values":["Johnson Anazoba Joseph"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier","label":"Identifier","values":["https://digitalcommons.du.edu/etd/2120"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description.abstract","label":"Abstract","values":["The aberrant fibrous, extracellular, and intracellular proteinaceous deposits in cells, organs and tissues are referred to as amyloids. These deposits are dominated by β-sheet structures that have been implicated in several neurodegenerative diseases and cancer. In this work, the types of amyloidosis studied include Parkinson’s disease (PD) using UA196 and NL5901 strains of Caenorhabditis elegans (C. elegans), Alzheimer’s disease (AD) using GMC101 strain of C. elegans, and cancer-associated mutant p53 aggregation in MIA PaCa-2 mutant cells. Several molecules including SK-129, NS132, NS163, bexarotene, a polyphenol (-)-epi-gallocatechine gallate (EGCG), ADH40, RD148, and RD242 were screened in vitro and in vivo while studying the inhibition of the amyloid protein aggregation. Also, the prion-like spread of amyloid fibrils was studied (through secondary nucleation) in NL5901 strain of C. elegans using α-Synuclein (αS) preformed fibrils and in MIA-PaCa-2 cells using p53 preformed fibrils. Various techniques were used in this study including paralysis assay, Thioflavin T (ThT) assay, immunofluorescence (IF) assay, confocal imaging, Proteomics analysis, Western Blot (WB) analysis to study the locomotion of C. elegans, to determine the amyloid fibril content in vitro and in vivo, determine upregulated and downregulated proteins in cells, and identify target proteins through immunoblotting of cell lysates, respectively. Oligopyridylamides (OPs) and Oligoquinolines (OQs) displayed remarkable neuroprotective effects in DA neurons and rescued various PD phenotypes of C. elegans, including rescue of degeneration of DA neurons, improved motility rate, decreased reactive oxygen species, food-sensing behavioral deficits, and rescue of dopamine synthesis. Also, we demonstrated that OPs rescue PD phenotypes when administered to the post-disease-onset C. elegans model. The results from this study proposed that SK-129, NS132, NS163, bexarotene, EGCG, ADH40, RD148, and RD242 are potent antagonists for amyloid protein aggregation."]},{"key":"dc:description.provenance","label":"Dc Description Provenance","values":["Received from ProQuest"]},{"key":"dc:format","label":"Dc Format","values":["application/pdf"]},{"key":"dc:format.extent","label":"Dc Format Extent","values":["114 pgs"]},{"key":"dc:title","label":"Title","values":["Inhibition of de novo and the Prion-Like Spread of Amyloidogenesis Using in vitro and in vivo Disease Models"]}]}],"canonical_facts":{"dc:contributor":["Sunil Kumar","Daniel Linseman","Martin Margittai","Michelle K. Knowles"],"dc:creator":["Joseph, Johnson Anazoba"],"dc:date.available":["2023-04-30T07:00:00Z"],"dc:date.copyright":["2022-01-01T08:00:00Z"],"dc:date.created":["2022-01-01T08:00:00Z"],"dc:description.abstract":["The aberrant fibrous, extracellular, and intracellular proteinaceous deposits in cells, organs and tissues are referred to as amyloids. These deposits are dominated by β-sheet structures that have been implicated in several neurodegenerative diseases and cancer. In this work, the types of amyloidosis studied include Parkinson’s disease (PD) using UA196 and NL5901 strains of Caenorhabditis elegans (C. elegans), Alzheimer’s disease (AD) using GMC101 strain of C. elegans, and cancer-associated mutant p53 aggregation in MIA PaCa-2 mutant cells. Several molecules including SK-129, NS132, NS163, bexarotene, a polyphenol (-)-epi-gallocatechine gallate (EGCG), ADH40, RD148, and RD242 were screened in vitro and in vivo while studying the inhibition of the amyloid protein aggregation. Also, the prion-like spread of amyloid fibrils was studied (through secondary nucleation) in NL5901 strain of C. elegans using α-Synuclein (αS) preformed fibrils and in MIA-PaCa-2 cells using p53 preformed fibrils. Various techniques were used in this study including paralysis assay, Thioflavin T (ThT) assay, immunofluorescence (IF) assay, confocal imaging, Proteomics analysis, Western Blot (WB) analysis to study the locomotion of C. elegans, to determine the amyloid fibril content in vitro and in vivo, determine upregulated and downregulated proteins in cells, and identify target proteins through immunoblotting of cell lysates, respectively. Oligopyridylamides (OPs) and Oligoquinolines (OQs) displayed remarkable neuroprotective effects in DA neurons and rescued various PD phenotypes of C. elegans, including rescue of degeneration of DA neurons, improved motility rate, decreased reactive oxygen species, food-sensing behavioral deficits, and rescue of dopamine synthesis. Also, we demonstrated that OPs rescue PD phenotypes when administered to the post-disease-onset C. elegans model. The results from this study proposed that SK-129, NS132, NS163, bexarotene, EGCG, ADH40, RD148, and RD242 are potent antagonists for amyloid protein aggregation."],"dc:description.provenance":["Received from ProQuest"],"dc:format":["application/pdf"],"dc:format.extent":["114 pgs"],"dc:identifier":["https://digitalcommons.du.edu/etd/2120"],"dc:language":["en"],"dc:rights":["<p>Copyright is held by the author. User is responsible for all copyright compliance.</p>"],"dc:rights.holder":["Johnson Anazoba Joseph"],"dc:subject":["Alzheimer's disease","Amyloids","Caenorhabditis elegans","Cancer","Neurodegenerative diseases","Parkinson's disease","Biochemistry","Biochemistry, Biophysics, and Structural Biology","Cancer Biology","Cell and Developmental Biology","Cell Biology"],"dc:title":["Inhibition of de novo and the Prion-Like Spread of Amyloidogenesis Using in vitro and in vivo Disease Models"],"thesis:degree_level":["Masters Thesis"],"thesis:degree_name":["M.S."]},"updated_at":"2026-11-19T07:54:25Z"}